↓ Skip to main content

CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy

Overview of attention for article published in Journal of Hematology & Oncology, November 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (63rd percentile)
  • Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter
7 tweeters

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
94 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
Published in
Journal of Hematology & Oncology, November 2019
DOI 10.1186/s13045-019-0819-1
Pubmed ID
Authors

Delong Liu

Twitter Demographics

The data shown below were collected from the profiles of 7 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 94 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 94 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 15 16%
Student > Master 13 14%
Researcher 12 13%
Student > Doctoral Student 8 9%
Student > Ph. D. Student 7 7%
Other 15 16%
Unknown 24 26%
Readers by discipline Count As %
Medicine and Dentistry 24 26%
Biochemistry, Genetics and Molecular Biology 16 17%
Pharmacology, Toxicology and Pharmaceutical Science 6 6%
Unspecified 4 4%
Immunology and Microbiology 4 4%
Other 10 11%
Unknown 30 32%

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 November 2019.
All research outputs
#5,790,016
of 19,847,691 outputs
Outputs from Journal of Hematology & Oncology
#317
of 1,020 outputs
Outputs of similar age
#123,954
of 343,129 outputs
Outputs of similar age from Journal of Hematology & Oncology
#51
of 116 outputs
Altmetric has tracked 19,847,691 research outputs across all sources so far. This one has received more attention than most of these and is in the 70th percentile.
So far Altmetric has tracked 1,020 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.2. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 343,129 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.
We're also able to compare this research output to 116 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 56% of its contemporaries.